Excellence in Running Local and Multi-Region Clinical Trials with a Global Clinical Supply Services Provider (Conducted in Japanese)
Date: September 30, 2021
Time: 3 PM Japan Standard Time
Speaker: Nakaya (Nick) Matsumaru, General Manager, Catalent Clinical Supply Services, Shiga
The attractiveness of Japan’s pharmaceutical sector for inward investment has further increased in recent years following concerted efforts by Japanese regulatory authorities to align drug approval timelines with those in the U.S. and Europe. With the evolution and development of the International Council on Harmonisation, running clinical trials in Japan is now much easier than in previous times. This has been further strengthened by the removal of significant regulatory and bureaucratic obstacles for clinical trials, such as permitting bridging studies as opposed to requiring full participation in clinical development worldwide.
Nonetheless, the complexities of planning and executing clinical trial supply in and out of Japan can be daunting, and if the supply chain considerations are not well understood, sponsors can experience increased risk, time, and cost as they run trials in Japan and beyond.
This webinar which will be conducted in Japanese, will explore the considerations that you need to make, and solutions you can employ to help optimize your local and global trial supply.
LEARN MORE ABOUT:
- The clinical supply challenges for global studies
- The considerations you need to make when planning clinical supply for local and global studies involving Japan
- How working with fewer suppliers can help reduce risk, time and cost associated with your clinical trials
- Catalent’s new 6,000m2 facility in Shiga, one of the largest clinical supply facilities in Japan